1. Home
  2. MAIA vs PRTS Comparison

MAIA vs PRTS Comparison

Compare MAIA & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • PRTS
  • Stock Information
  • Founded
  • MAIA 2018
  • PRTS 1995
  • Country
  • MAIA United States
  • PRTS United States
  • Employees
  • MAIA N/A
  • PRTS N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • PRTS Auto & Home Supply Stores
  • Sector
  • MAIA Health Care
  • PRTS Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • PRTS Nasdaq
  • Market Cap
  • MAIA 46.7M
  • PRTS 47.8M
  • IPO Year
  • MAIA 2022
  • PRTS 2007
  • Fundamental
  • Price
  • MAIA $1.95
  • PRTS $0.89
  • Analyst Decision
  • MAIA
  • PRTS Buy
  • Analyst Count
  • MAIA 0
  • PRTS 2
  • Target Price
  • MAIA N/A
  • PRTS $1.40
  • AVG Volume (30 Days)
  • MAIA 283.6K
  • PRTS 655.1K
  • Earning Date
  • MAIA 05-09-2025
  • PRTS 07-29-2025
  • Dividend Yield
  • MAIA N/A
  • PRTS N/A
  • EPS Growth
  • MAIA N/A
  • PRTS N/A
  • EPS
  • MAIA N/A
  • PRTS N/A
  • Revenue
  • MAIA N/A
  • PRTS $569,935,000.00
  • Revenue This Year
  • MAIA N/A
  • PRTS $1.73
  • Revenue Next Year
  • MAIA N/A
  • PRTS $5.48
  • P/E Ratio
  • MAIA N/A
  • PRTS N/A
  • Revenue Growth
  • MAIA N/A
  • PRTS N/A
  • 52 Week Low
  • MAIA $1.40
  • PRTS $0.68
  • 52 Week High
  • MAIA $4.31
  • PRTS $1.45
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 57.09
  • PRTS 52.54
  • Support Level
  • MAIA $1.71
  • PRTS $0.85
  • Resistance Level
  • MAIA $1.81
  • PRTS $0.94
  • Average True Range (ATR)
  • MAIA 0.09
  • PRTS 0.05
  • MACD
  • MAIA 0.00
  • PRTS 0.01
  • Stochastic Oscillator
  • MAIA 70.59
  • PRTS 74.00

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Share on Social Networks: